Related Experiment Video
Updated: May 15, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Transcutaneous vaccines--current and emerging strategies
Sachiko Hirobe1, Naoki Okada, Shinsaku Nakagawa
1Osaka University, Graduate School of Pharmaceutical Sciences, Laboratory of Biotechnology and Therapeutics, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
Transcutaneous immunization (TCI) offers a painless, easy-to-use alternative to traditional vaccines, overcoming barriers in developing nations. Further research into skin properties and TCI devices is needed to refine manufacturing and clinical guidelines for widespread adoption.
Area of Science:
- Immunology
- Biotechnology
- Dermatology
Background:
- Vaccination is crucial for global health but faces delivery challenges in developing countries.
- Conventional injection systems present disadvantages that limit vaccine accessibility.
- Transcutaneous immunization (TCI) presents an innovative, user-friendly vaccination method.
Purpose of the Study:
- To review current strategies for transcutaneous immunization (TCI).
- To discuss advancements in adjuvant development for TCI.
- To highlight challenges and future directions for TCI implementation.
Main Methods:
- Review of TCI strategies including patch systems and nanoparticles for antigen permeation.
- Exploration of physical methods like electroporation and microneedles to bypass the skin barrier.
- Discussion on the role of adjuvants in enhancing TCI efficacy.
Main Results:
- TCI approaches aim to promote antigen skin permeation or physically breach the skin barrier.
- Nanoparticles, patches, electroporation, and microneedles are key technologies explored for TCI.
- Adjuvant development is a critical component for optimizing TCI effectiveness.
Conclusions:
- Various TCI methods show potential for effective, painless, and convenient vaccination.
- Manufacturing and clinical trial guidelines for TCI lag behind technological development.
- Further understanding of skin physiology and TCI device properties is essential for refining guidelines and improving transcutaneous vaccination.
Related Concept Videos
Vaccinations
Transdermal Drug Delivery Systems
Vaccines
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Site-Targeted Drug Delivery Systems: Polymeric Carriers

